Cell Therapy Technologies Market based on By Therapy Type (Autologous, Allogenic), By Therapeutic Area (Oncology, CVD, Dermatology), By Region - Global Forecast up to 2030

Cell therapy is important in giving diagnostic and prognostic information for a variety of disorders, including HIV/AIDS, cancer, and infectious diseases. It helps academics and healthcare practitioners to acquire insights into disease causes, illness development, and therapy responses using novel cellular-based techniques. Global population expansion, climate change, and greater human-animal interaction have produced an environment conducive to the genesis of novel viral epidemics. Cell therapy research and applications are critical in tackling these issues because they provide enhanced diagnostic tools, therapeutic approaches, and a better knowledge of disease causes.

Cell biology research is primarily concerned with the development of novel medicines such as stem cell and gene therapies. High-quality tools, reagents, and associated goods are required for reliable findings. Meeting regulatory rules and maintaining demanding quality standards in cell biology research, on the other hand, comes at a considerable expense. This is a problem for institutes and small businesses with limited funds, as they may be unable to acquire pricey research products.

Precision medicine is a developing approach to illness treatment and prevention that takes into account genetic, environmental, and lifestyle factors. It entails selecting drugs for each patient depending on their individual condition and medical history. Oncology has made significant advances in precision medicine, even as its use expands to diverse disorders. This personalised approach to diagnosis, treatment, and prevention makes better judgements by utilising full patient information such as genetics, environment, and lifestyle.

The segmentation coverage of the study is provided below.

Cell Therapy Technologies Market based on Therapy Type

• Allogeneic Therapies
• Stem Cell Therapies

 Hematopoietic Stem Cell Therapies

 Mesenchymal Stem Cell Therapies

• Non-Stem Cell Therapies

 Keratinocytes & Fibroblast-based Therapies

 Others

• Autologous Therapies
• Stem Cell Therapies

 BM, Blood, & Umbilical Cord-derived Stem Cells

 Adipose derived cells

 Others

• Non-Stem Cell Therapies

 T-Cell Therapies

 CAR T Cell Therapy

 T Cell Receptor (TCR)-based

Cell Therapy Technologies Market based on Therapeutic Area

• Oncology
• Cardiovascular Disease (CVD)
• Musculoskeletal Disorders
• Dermatology
• Others

Cell Therapy Technologies Market based on Geography

• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe (RoE)
• Asia Pacific (APAC)
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
• Brazil
• Argentina
• Rest of South America
• Middle East and Africa (MEA)
• UAE
• Turkey
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

On the basis of cell type, the stem cell segment led the worldwide cell therapy market in 2019, and this trend is expected to continue during the forecast period, as they are gaining popularity as a result of different government initiatives. The number of stem cell banks is increasing in developing countries, which is fueling the expansion of the cell treatment industry. Furthermore, increased understanding of stem cell preservation has a beneficial impact on the cell treatment market growth. Furthermore, the allogenic treatment segment dominated the market in 2019. This therapy is favourable because it includes the generation of one's own immune stem cells, which can destroy cancer cells that survive treatment with high-dose cytotoxic medicines.

It is divided into two types of therapies: autologous and allogenic. The market is divided by therapeutic areas such as malignancies, musculoskeletal diseases, autoimmune disorders, dermatology, and others. It is divided into two types of end-users: hospitals and clinics and academic and research institutes. The market is divided into four regions: North America (the United States, Canada, and Mexico), Europe (Germany, the United Kingdom, France, Spain, Italy, and the rest of Europe), Asia-Pacific (Japan, China, India, Australia, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and the rest of LAMEA).

The hospitals and clinics category is expected to develop at the fastest CAGR throughout the projection period. The segment's profitable expansion may be linked to an increase in the number of pipeline developments over the last few years. According to CRI, the number of cell therapy treatment projects climbed from 753 in 2018 to 1,011 in 2019.

Due to population growth, a growing geriatric population, and increased awareness among healthcare entities and patients about the potential of these therapies in chronic disease management, Asia-Pacific presents lucrative opportunities for key players operating in the cell therapy market. Furthermore, rising healthcare expenditures and the development of guidelines are projected to drive market expansion in the area.

Kolon Tissue Gene, Inc., Osiris Therapeutics, Inc., JCR Pharmaceuticals Co. Ltd., NuVasive, Inc., Stemedica Cell Technologies, Inc., Cells for Cells, Holostem Terapie Avanzate S.r.l., Mesoblast Ltd., and Medipost Co., Ltd. are among the leading companies operating in the global cell therapy market.

• This report illustrates the most vital attributes of the Cell Therapy Technologies Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Cell Therapy Technologies Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Cell Therapy Technologies Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Cell Therapy Technologies Market.

Show more